|
MANDATORY LABORATORY TESTING
For Client Depositor and Directed or Designated Donor
Laboratory testing is required of Client Depositor and Directed or Designated Donor. The laboratory tests are performed to protect the recipient.
| Client Depositor Laboratory testing |
| HIV-1/2 screening |
Hepatitis C Virus antibody |
| Blood Group/Rh |
Hepatitis B Surface antigen |
| HTLV 1&2 |
Syphilis serology screen |
| Additional testing for Clients storing Semen |
| Gonorrhea culture |
Myco/Ureaplasma culture |
| Bacterial culture |
Chlamydia/PCR |
| Directed/Designated Donor Laboratory Testing |
| I-THE INITIAL EVALUATION |
| Blood Group and Rh |
Chemistry Profile |
| Hepatitis C Virus antibody |
HTLV-I&II |
| HIV-1/2 screening |
Chlamydia/ PCR |
| Cytomegalovirus screen |
Herpes Virus culture |
| Gonorrhea culture |
B-Thalassemia screen |
| Myco/Ureaplasma culture |
Cystic Fibrosis screen |
| Sickle Cell screen |
Complete Blood Count |
| Syphilis serology screen |
Urinalysis |
| Tay Sachs screen |
Bacterial culture |
| Hepatitis B Surface antigen |
Hepatitis B Core antibody |
| Urine Drug screen |
Karyotyping/Chromosome Analysis |
| IN ADDITION ALL JEWISH DONORS ARE TESTED FOR THE FOLLOWING |
| Gaucher Disease |
Canavan Disease |
Niemann-Pick Disease |
| II. LABORATORY TESTING TO BE PERFORMED PRIOR TO THE RELEASE AND AT THE END OF THE QUARANTINE PERIOD OF SIX CONSECUTIVE MONTHS OF STORAGE. |
| Syphilis serology screen |
Hepatitis B Core antibody |
| Hepatitis C Virus antibody |
HTLV-I&II |
| Chemistry profile |
HIV-1/2 screening |
NO TESTS ARE PERFORMED FOR cancer markers or multiple sclerosis.
Warning: Even if the tests described in the preceding paragraph were found to be within normal limits, and even when properly administered, the tests have their own limitations and may not produce reliable results. Consequently, Physician/Medical Facility and its patient(s) take the risk that certain cells & tissue specimens will not be disease free even though the test results may indicate otherwise.
|
